DONATE

Biosensors for bioengineering

Group

“Revealing the Invisible”: IBEC marks its 20th anniversary by turning research images into cyanotypes

To mark its 20th anniversary, the Institute for Bioengineering of Catalonia (IBEC) has launched “Revealing the Invisible”, an art and science project in which photographer Roser Salarich has transformed twenty images contributed by the institute’s research groups into cyanotypes, one for each year of its history. The exhibition was unveiled at the institutional event celebrating the anniversary and could be visited during IBEC’s annual Symposium.

IBEC celebrates two decades of bioengineering at its 20th Anniversary Symposium, with more than 350 attendees

The Institute for Bioengineering of Catalonia (IBEC) marked its 20th anniversary with a special edition of its annual Symposium, under the theme ‘20 years shaping the present and future of medicine with bioengineering’. Over two days, more than 350 members of the IBEC community met in Barcelona to share their work, discuss the latest advances in bioengineering and celebrate two decades of interdisciplinary research at the institute.

From the classroom to the laboratory: summer stays at IBEC

As every year, as soon as the school year ends, IBEC’s laboratories fill up with a new generation of future scientists. This summer, more than 20 secondary school, high school and undergraduate students took part in various programmes, gaining first-hand experience of the day-to-day work of bioengineering research in nine of the centre’s laboratories.

IBEC staff gather for IBEC Day to mark the institute’s 20th anniversary

Over 200 people took part in IBEC Day 2026, an event designed to encourage sharing, connection and celebration in honour of the institute’s 20th anniversary.

Together with Patients with Duchenne, IBEC is developing a ‘heart-on-a-chip’ to halt the cardiac damage caused by the condition

Duchenne Parent Project Spain has invested €247,000 in the BEAT project, which will be carried out by the Institute for Bioengineering of Catalonia (IBEC).  Cardiomyopathy is the leading cause of death in patients with Duchenne muscular dystrophy (DMD). Around 20,000 new Duchenne cases are diagnosed globally each year.

IBEC makes its mark at TERMISEU 2026 with a strong scientific presence and a key role in the conference’s leadership

From 21 to 24 April 2026, IBEC had a significant presence at TERMISEU 2026, the leading European conference on tissue engineering and regenerative medicine. Held at the Palma Conference Centre in Mallorca, the event brought together more than 1,600 researchers.

BIST calls for reforms to turn scientific discoveries into European industry

The BIST Forum 2026 brought together scientists and representatives from academic, economic and social institutions to discuss how frontier research can help build Europe’s industries of the future. The event also announced the recipients of the BIST To the Mothers of Science and Ignite programmes.

IBEC secures competitive funding to drive forward validation testing for three innovative health projects

IBEC has been awarded three grants in response to the call for proposals from the Strategic Plan for Health Research and Innovation (PERIS). These projects aim to validate hyperspectral technology for improving assisted reproduction, using bioprinted cell spheroids to combat type 1 diabetes and developing light-activated drugs to restore vision in patients with retinal degeneration.

The IBEC and West China Hospital hold their third joint conference on precision medicine in Barcelona

Barcelona hosted the third IBEC-WCH Precision Medicine Conference this week, an event that further strengthened the strategic alliance between the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital of Sichuan University (WCHSU). The Chinese delegation visited Spain from 26 to 29 November, taking part in a busy schedule of scientific and institutional activities and exchanges between the two centres.

Fibrosens Project receives funds from AFM-Telethon to develop sensor devices for muscular dystrophy

IBEC researchers Chiara Ninfali (left) and Juanma Fernández (right).

IBEC researcher Juanma Fernández recently has received funding from the French AFM-Telethon to carry out the project “Monitoring of fibrotic processes in 3D skeletal muscle co-cultures for Muscular Dystrophies using plasmonic biosensors”. The objective is to develop multiplexing sensor devices to achieve online, real-time sensing capability to monitor fibrosis markers and evaluate drug response in muscular dystrophy in vitro models.